Menu
Search
|

Menu

Close
X

Tactile Systems Technology Inc TCMD.OQ (NASDAQ Stock Exchange Global Market)

58.52 USD
-0.05 (-0.09%)
As of Nov 16
chart
Previous Close 58.57
Open 58.22
Volume 91,923
3m Avg Volume 82,350
Today’s High 60.70
Today’s Low 58.12
52 Week High 73.22
52 Week Low 25.67
Shares Outstanding (mil) 18.47
Market Capitalization (mil) 1,121.28
Forward P/E 151.82
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.14 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY18
97
FY17
109
FY16
85
FY15
63
EPS (USD)
FY18
0.220
FY17
0.362
FY16
0.086
FY15
-0.027
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
151.82
29.34
Price to Sales (TTM)
vs sector
8.48
20.58
Price to Book (MRQ)
vs sector
13.40
4.23
Price to Cash Flow (TTM)
vs sector
102.42
21.19
Total Debt to Equity (MRQ)
vs sector
0.00
13.84
LT Debt to Equity (MRQ)
vs sector
0.00
9.93
Return on Investment (TTM)
vs sector
9.99
13.58
Return on Equity (TTM)
vs sector
10.14
15.11

EXECUTIVE LEADERSHIP

Peter Soderberg
Independent Chairman of the Board, Since 2012
Salary: --
Bonus: --
Gerald Mattys
Chief Executive Officer, Director, Since 2005
Salary: $443,846.00
Bonus: $449,880.00
Brent Moen
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Robert Folkes
Chief Operating Officer, Since 2015
Salary: $306,923.00
Bonus: $195,600.00
Juleen Krings
Chief Human Resource Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1331 Tyler St NE Ste 200
MINNEAPOLIS   MN   55413-1638

Phone: +1612.3555100

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

SPONSORED STORIES